A. Ari Hakimi

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• LGE-D: Conservative Zero-Training Diagnostic Gatekeeper for Time-Series Forecasting

  Zenodo (CERN European Organization for Nuclear Research) · 2026-06-26

• LGE-D: Conservative Zero-Training Diagnostic Gatekeeper for Time-Series Forecasting

  Zenodo (CERN European Organization for Nuclear Research) · 2026-06-26

• Urolithiasis in patients with cancer

  Nature Reviews Urology · 2026-06-22

• Quantitative Assessment of the Readability of Patient Education Material by the Society of Vascular Surgery

  Annals of Vascular Surgery · 2026-05-06

• Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

  CA A Cancer Journal for Clinicians · 2025-12-13

• Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma

  Cancers · 2025-11-29

• Supplementary Tables S6-S8 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

  2025-11-25

• Supplementary Tables S1-S5 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

  2025-11-25

• The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

  Nature Communications · 2025-11-14 · 3 citations

• MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma

  European Urology · 2025-11-01

• Hypoxia and tumor associated macrophages shape response to immune and angiogenesis-targeted therapies in metastatic clear cell renal cell carcinoma 3738

  The Journal of Immunology · 2025-11-01

• Influence of sex on immunosurveillance and metastatic tropism in novel mouse models of clear cell renal cell carcinoma 4060

  The Journal of Immunology · 2025-11-01

• 47TCF1+ CD4+ T cells mediate response to anti-CTLA-4 therapy in a sarcomatoid RCC mouse model

  The Oncologist · 2025-10-01

• Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium

  The Lancet Oncology · 2025-10-01 · 8 citations

• 34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma

  The Oncologist · 2025-10-01

• A health-system-scale, episode-resolved multimodal atlas of cancer cachexiaPreprint

  medRxiv · 2025-09-30 · 2 citations

• Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma

  European Urology · 2025-09-08 · 2 citations

• Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma

  Urologic Oncology Seminars and Original Investigations · 2025-09-05

• Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma—An Observational Prospective Multicentre Diagnostic Test Cohort Study

  European Urology Oncology · 2025-08-27 · 5 citations

• Noninvasive Ventilation on Acute Hypoxemic Respiratory Failure: Analysis of Therapeutic Impact in an Observational study

  Batna Journal of Medical Sciences (BJMS) · 2025-08-25